← Yangiliklar markaziga qaytish
Sog‘liq
FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment
Manba: U.S. Food and Drug Administration (FDA)
E’lon qilingan:
Tarjima qilinmagan — asl tilda ko‘rsatilgan (ingliz tili).
Manba bergan mazmun — U.S. Food and Drug Administration (FDA)
FDA today approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.
Bu sahifada nashriyot bildirgan ma’lumot keltirilgan. MYITEDU bu da’volarni mustaqil tekshirmagan.
Asl maqolani o‘qish — U.S. Food and Drug Administration (FDA) ↗
Manba ko‘rsatilishi: Source: U.S. Food and Drug Administration (fda.gov)
Ulashish
Instagram saytlardan havola ulashishni qo‘llab-quvvatlamaydi. Kartani yuklab oling, Instagram ilovasida joylang va izohni qo‘ying.
Tuzatish haqida xabar berish
Materialdagi, tarjimadagi, sanadagi yoki manba ko‘rsatilishidagi xato haqida xabar bering. Aloqa ma’lumotlaringiz maxfiy saqlanadi va faqat javob berish uchun ishlatiladi.